• One Health
  • Pain Management
  • Anesthesia
  • Geriatric & Palliative Medicine
  • Ophthalmology
  • Pathology
  • Infectious Diseases
  • Dermatology
  • Theriogenology
  • Animal Welfare
  • Radiology
  • Internal Medicine
  • Dentistry
  • Feline Medicine
  • Surgery
  • Avian & Exotic
  • Preventive Medicine
  • Anesthesiology & Pain Management
  • Integrative & Holistic Medicine
  • Behavior
  • Zoo Medicine
  • Toxicology
  • Orthopedics
  • Emergency & Critical Care
  • Equine Medicine
  • Pharmacology
  • Pediatrics
  • Parasitology
  • Clinical Pathology
  • Rehabilitation
  • Epidemiology
  • Aquatic Medicine
  • Livestock

Swine Antibiotic

Article

Novartis announces the purchase of Denagard? (tiamulin), a broad-spectrum swine antibiotic for control and treatment of certain swine bacterial diseases.

Novartis announces the purchase of Denagard® (tiamulin), a broad-spectrum swine antibiotic for control and treatment of certain swine bacterial diseases.

The company announced an agreement with Boehringer Ingelheim Vetmedica that enabled Novartis to acquire the Denagard brand.

The acquisition represents a step in the company's efforts to strengthen its position in the livestock industry, the company says.

Denagard treats enteric and respiratory diseases. Denagard Medicated Premix is labeled for control of ileitis associated with Lawsonia intracellularis, and the treatment and control of swine dysentery associated with Brachyspira (Serpulina) hyodysenteriae.

The liquid concentrate form is for the treatment of swine dysentery associated with Brachyspira (Serpulina) hyodysenteriae and swine pneumonia due to Actinobacillus pleuropneumoniae.

For fastest response, call

(800) 843-3386

www.livestock.novartis.com/denagard.html

Related Videos
© 2024 MJH Life Sciences

All rights reserved.